-
Council's Director General Dr Rajiv Bahl says the BHU study erroneously "acknowledges" ICMR
-
Bharat Biotech said that its Covid-19 vaccine Covaxin has an excellent safety record without any vaccine-associated incidents of blood clots, thrombocytopenia, etc.
-
In fact, the study found that there were less chances of death after heart attack in vaccinated individuals.
-
Public Health Director Srinivasa Rao said that the 'Carbo vaccine' will be provided as a booster dose across the State from Wednesday and five lakh doses have been kept ready for this purpose.
-
The ecosystem at Genome Valley facilitates many startups and R&D centres to emerge at the national and international levels
-
Between June 2021 and January 2022, the researchers enrolled 691 participants in the 18-45 age group across four sites in urban and rural Bengaluru and Pune.
-
The company in a statement issued on Thursday said the narrative against Covaxin was put forth by a select few individuals and groups who had no expertise in vaccines or vaccinology.
-
New Delhi: The Central government has approved Biological E’s Corbevax for restricted use in an emergency as a heterologous booster dose, official sources confirmed on Wednesday. On Tuesday, ANI had reported that Corbevax booster for heterologous first has been approved by the Centre. Last month the National Technical Advisory Group on Immunisation (NTAGI) recommended Biological […]
-
Hyderabad: Covid vaccine maker Bharat Biotech International Limited (BBIL), announced that its Covaxin (BBV152), has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study. The study has been accepted and published in Lancet Infectious Diseases, a peer reviewed journal. Bharat Biotech had conducted phase II/III, open-label, and multi-centre study […]
-
Hyderabad: Bharat Biotech International announced that its Covaxin has received emergency use approval in children aged between 6 and 12 years. It had conducted phase II/III, open-label, and multicenter studies to evaluate the safety, reactogenicity, and immunogenicity Covaxin in healthy children and adolescents in the 2-18 age group. The clinical trials conducted in the paediatric […]
-
New Delhi: The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said. This development comes after the Subject Expert Committee discussed recommendations for the restricted emergency of Covaxin in […]
-
Hyderabad: Biotechnology company Ocugen will commercialise Bharat Biotech’s Covaxin in Mexico. The two companies amended their present co-development, supply and commercialisation agreement on Bharat Biotech’s Covid-19 vaccine Covaxin to include Mexico. With this amendment, Ocugen now has commercialisation rights of Covaxin for all of North America. “We’re excited to commercialise Covaxin in Mexico, as authorities […]
-
Hyderabad: A day before Covid vaccine booster shots become available to all adult population, prices of Covaxin and Covidshield have been reduced to Rs 225 per dose for private hospitals. Suchitra Ella, Co-Founder and Joint Managing Director of Covaxin maker Bharat Biotech announced the decision on the micro-blogging platform Twitter. “We welcome the decision to […]
-
New Delhi: Hyderabad-based vaccine manufacturer Bharat Biotech on Friday announced the temporary slowing down of its Covid vaccine Covaxin’s production across its manufacturing facilities. “Bharat Biotech today announces the temporary slowing down of production of Covaxin across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand,” it […]
-
Hyderabad: Padma Bhushan awardees Dr Krishna Ella and Suchitra Ella had moved to the US in late 1980s with just two suitcases and 14 years later when they decided to return to India, they had come back with a 40 feet container. “This container did not have our personal belongings but 70 per cent of […]
-
Hyderabad: The next pandemic, if it comes, will be on the animal side and food security issues, predicted Krishna Ella, Founder and Chairman of Bharat Biotech, that created the Covaxin. “I predict that, if the next pandemic comes, it will be on the animal side and food security issues. We do not want it to […]
-
Hyderabad: Telangana on Tuesday reached yet another milestone in Covid vaccination drive when the health department completed administering first dose of Covid vaccine to 100 percent of the eligible beneficiaries between 15 years and 17 years of age group in Hanamkonda district. The vaccination drive for youngsters was launched on January 3 and as on […]
-
Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting besides recording all vaccinations done within the country on the CoWIN platform, the sources said.
-
New Delhi: Hyderabad-based Bharat Biotech on Wednesday claimed that its COVID vaccine Covaxin can neutralise both Delta and Omicron variants of coronavirus. In a statement, Bharat Biotech said, “Results from a study conducted at Emory University demonstrating that sera from subjects who received a booster dose of Covaxin (BBV152) six months after getting a primary […]
-
Hyderabad: Two persons who allegedly stole Covaxin and Covishield vaccine vials from a government health centre in the old city were arrested by the Mirchowk police on Tuesday. The police recovered the vaccines and other stolen articles from them. The arrested persons were Javeed Khan alias Jadoo (28) and Ghouse Pasha (27), both residents of […]
